Coronavirus: EU approves AstraZeneca PLC vaccine for all over-18s, Novavax jab shown to be 89% effective
The approval will come hours after the EU published the contract signed with the pharma giant to back up its requests
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 25 of 55
Coronavirus: Row between AstraZeneca and EU continues as Germany advises against use on over 65s for lack of efficacy data
Meanwhile, French firm Valneva has begun large-scale vaccine manufacturing in Scotland
AstraZeneca confident UK can hit Covid-19 target as Sanofi agrees to make vaccine for Pfizer
UK deaths attributed to virus rose to more than 100,000 yesterday
Coronavirus: AstraZeneca defends against vaccine allegations amid EU tit-for-tat over Pfizer jab
AstraZeneca can only deliver half of the doses promised for the first quarter but officials said the explanations were insufficient
AstraZeneca says China approves mild asthma reliever
Symbicort Turbuhaler was already approved in the Asian country for patients with moderate to severe symptoms
AstraZeneca receives approval in Japan for leukaemia drug
The same candidate, Calquence, also met its main goal in another trial on blood cancer patients
Pfizer/BioNTech coronavirus vaccine effective against UK variant suggests study
The co-founders of BioNTech were involved in the study
AstraZeneca says EU approves breast cancer drug
Over half a million women in Europe are diagnosed with the disease annually
Coronavirus: UK vaccine supply hindered by manufacturing issues, London to pilot 24/7 inoculation sites…
The latest news on the UK's COVID-19 vaccination programme
AstraZeneca receives US approval for stomach cancer drug
Enhertu can be now used to treat adults with locally advanced or metastatic tumours that have higher than normal levels of a protein called HER2
AstraZeneca says EU, UK approve cancer drug for additional dosing option
This new dosing option is consistent with the approved Imfinzi dosing in another type of tumour
Coronavirus: High street pharmacies start vaccine rollout as Boris Johnson promises 24/7 injections
In today's coronavirus news, updates on the vaccine programme in the UK and results from a study on former patients
Coronavirus: UK progresses with vaccine rollout, Bayer partners with CureVac, US monitors allergic reactions
There were various major developments regarding COVID-19 vaccines on Thursday
Coronavirus: UK may face tougher restrictions as Boris Johnson to address nation on Monday night
Meanwhile, Scotland is entering lockdown on Monday at midnight
Coronavirus: UK starts rollout of AstraZeneca/Oxford vaccine
The FTSE 100 firm has provided 530,000 doses ready for use on Monday at six hospital trusts
AstraZeneca completes sale of heart failure treatment commercial rights for US$400mln
The buyer is German pharma company Cheplapharm, which paid US$250mln on completion of the deal and will pay the balance in the first half of 2021
Archive
FTSE 100 closes the year 15% below January levels under coronavirus, Brexit pressure
The FTSE 100 index closed out the last session of this benighted year 95.30 points lower at 6,460.52, a level last seen in July 2016
Millions in UK placed in Tier-4 as mutant COVID-19 strain spreads
Hancock said that recent surge in infections had made tougher restrictions necessary across the country.
AstraZeneca and Oxford University COVID-19 vaccine given UK go-ahead
People aged 18 or over will receive two shots of the vaccine with the second dose administered 4-12 weeks after the first.
Archive
FTSE 100 closes lower on final full-day session of annus horribilis 2020
The UK blue-chip index closed down 46.83 points, or 0.7% at 6,555.82, only just above the session low of 6,552.466, and well below the early peak of 6,622.98